Lifevantage (LFVN) vs OS Therapies (OSTX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
OS Therapies (OSTX) has outperformed Lifevantage (LFVN) over the past year, losing 24.0% versus a loss of 35.1%. Lifevantage is the larger company by market cap ($76.0 million vs $74.1 million), about 1.0 times the size. On valuation, OS Therapies trades at a lower forward P/E (4.6x vs 15.6x for Lifevantage).
Lifevantage pays a dividend yielding 3.06%, while OS Therapies does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LFVN | OSTX |
|---|---|---|
| Share price | $6.04 | $1.58 |
| Market cap | $76.04M | $74.06M |
| 1-day change | +0.67% | +2.07% |
| YTD return | -2.60% | +10.71% |
| 1-year return | -35.14% | -24.02% |
| 5-year return | -12.02% | — |
| P/E ratio (TTM) | 15.10 | — |
| Forward P/E | 15.62 | 4.56 |
| EPS (TTM) | $0.40 | $-1.08 |
| Dividend yield | 3.06% | 0.00% |
| Annual dividend | $0.185 | $0.00 |
| 52-week high | $11.71 | $2.25 |
| 52-week low | $3.90 | $1.15 |
| Distance from 52-week high | -48.42% | -29.68% |
| Average volume | 61.18K | 597.09K |
| Shares outstanding | 12.59M | 46.81M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- OSTX has outperformed LFVN by 11.1 percentage points over the past year.
- Lifevantage offers a meaningfully higher dividend yield (3.06% vs 0.00%).
LFVN vs OSTX FAQ
Which is bigger, Lifevantage or OS Therapies?
Lifevantage (LFVN) is larger, with a market capitalization of $76.04M compared with $74.06M for OS Therapies (OSTX).
Which stock has performed better over the past year, LFVN or OSTX?
OSTX returned -24.02% over the past 12 months, compared with -35.14% for LFVN (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Lifevantage or OS Therapies?
Lifevantage pays a dividend yielding 3.06%, while OS Therapies does not currently pay a regular dividend.
Are Lifevantage and OS Therapies in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.